128 Participants Needed

ESP Block for Pain After Kidney Stone Surgery

JB
AP
Overseen ByAimee Pehrson
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: University of Tennessee Medical Center
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

Trial Summary

What is the purpose of this trial?

The purpose of this study is to investigate the use of the erector spinae (ESP) block in reducing the morphine milligram equivalent (MME) consumption post percutaneous nephrolithotomy. Objectives: 1. - Determine if there is a significant effect on post percutaneous nephrolithotomy MME consumption with the usage of an ESP block vs. saline control. 2. - Determine if there is a significant effect on reported pain levels with the use of an ESP block vs. saline control in post percutaneous nephrolithotomies.

Do I have to stop taking my current medications for this trial?

The trial protocol does not specify whether you need to stop taking your current medications. However, if you have been using opioids for more than 90 days in the past year, you cannot participate.

What data supports the idea that ESP Block for Pain After Kidney Stone Surgery is an effective treatment?

The available research shows that the Erector Spinae Plane Block (ESPB) is effective in managing pain after kidney stone surgery. One study found that patients who received ESPB had significantly lower pain scores at various times after surgery compared to those who did not receive the block. This suggests that ESPB provides better pain relief than standard intravenous pain medication. Additionally, patients who received ESPB were less agitated and had better breathing function after surgery, indicating additional benefits beyond pain relief.12345

What safety data is available for ESP block in kidney stone surgery?

The ESP block is described as a simple and safe method for postoperative analgesia in several studies. It is noted for its safety in providing analgesia after thoracolumbar surgeries and is considered an alternative to neuraxial block for post-surgical pain. However, specific safety data for ESP block in kidney stone surgery is not directly addressed in the provided research abstracts.12467

Is the ESP Block a promising treatment for pain after kidney stone surgery?

Yes, the ESP Block is a promising treatment for pain after kidney stone surgery. It is simple, safe, and provides good pain relief after surgery. It can also reduce the need for other pain medications.12789

Research Team

JB

Jason Buehler, MD

Principal Investigator

University of Tennessee Medical Center

Eligibility Criteria

This trial is for English-speaking adults over 18 who are having non-emergency kidney stone surgery (percutaneous nephrolithotomy) during weekdays. They must be able to understand and explain the consent process, and women of childbearing age need a negative pregnancy test.

Inclusion Criteria

Ability to understand and teach back consent for the procedure
Willingness to sign consent for procedure
I can have children and will provide a negative pregnancy test.
See 2 more

Exclusion Criteria

Opioid use >90 days in the year leading up to surgery
Pregnancy or breastfeeding
I do not have any health conditions that would make the trial unsafe for me.
See 6 more

Timeline

Screening

Participants are screened for eligibility to participate in the trial

1-2 weeks

Treatment

Participants undergo percutaneous nephrolithotomy and receive either an ESP block or a control block

1 day
1 visit (in-person)

Immediate Post-operative Monitoring

Participants are monitored for opioid consumption and pain levels using VAS scores in the first 24 hours post-surgery

24 hours

Follow-up

Participants are monitored for recovery quality and opioid use at 24 hours, 48 hours, 7 days, and 30 days post-surgery

30 days
4 visits (in-person or virtual)

Treatment Details

Interventions

  • Dexamethasone
  • Erector Spinae Plane Block
  • Ropivacaine 0.5% Injectable Solution
Trial Overview The study tests if an ESP block with Ropivacaine and Dexamethasone reduces painkiller needs after kidney stone surgery compared to a saline solution control. It also looks at its effect on reported pain levels post-surgery.
Participant Groups
2Treatment groups
Active Control
Placebo Group
Group I: ESP GroupActive Control3 Interventions
One 30mL syringe containing 30mL of 0.5% ropivacaine and 4 mg of dexamethosone-
Group II: Sham GroupPlacebo Group1 Intervention
One 30mL syringe containing 30mL of preservative free normal saline

Find a Clinic Near You

Who Is Running the Clinical Trial?

University of Tennessee Medical Center

Lead Sponsor

Trials
7
Recruited
450+

Findings from Research

Adding 20 mg of nalbuphine to ropivacaine in an erector spinae plane block significantly prolongs the time to first opioid demand after percutaneous nephrolithotomy, with a median time of 8.70 hours compared to 2.90 hours for ropivacaine alone.
The combination of nalbuphine and ropivacaine also reduces postoperative morphine consumption, indicating enhanced analgesic efficacy without compromising safety, as VAS pain scores remained comparable across all groups.
Analgesic Efficacy of Nalbuphine as an Adjuvant to Ropivacaine in Erector Spinae Plane Block for Percutaneous Nephrolithotomy: A Randomized, Double-Blinded, Clinical Trial.Sun, M., Wu, Z., Wang, R., et al.[2023]
In a clinical trial involving nephrectomy patients, those who received an erector spinae plane (ESP) block reported significantly lower pain scores in the first 24 hours post-surgery compared to those who did not receive the block.
The ESP block group also used fewer opioids and had better recovery quality, indicating that this technique may enhance postoperative pain management and improve patient outcomes.
Effect of ultrasound-guided erector spinae plane block on post-surgical pain in patients undergoing nephrectomy: a single-center, randomized, double-blind, controlled trial.Şahin, A., Baran, O.[2022]
The erector spinae plane block (ESPB) significantly reduced the need for opioids post-surgery, with lower total morphine consumption in the first 48 hours compared to intravenous patient-controlled analgesia (PCA).
Patients receiving ESPB experienced longer time to first analgesic request and lower pain scores at rest and during movement, indicating more effective pain management after open nephrectomy for renal malignancies.
Ultrasound Guided Continuous Erector Spinae Plane Block versus Patient Controlled Analgesia in Open Nephrectomy for Renal Malignancies: A Randomized Controlled Study.Abdelgalil, AS., Ahmed, AM., Gamal, RM., et al.[2022]

References

Analgesic Efficacy of Nalbuphine as an Adjuvant to Ropivacaine in Erector Spinae Plane Block for Percutaneous Nephrolithotomy: A Randomized, Double-Blinded, Clinical Trial. [2023]
Effect of ultrasound-guided erector spinae plane block on post-surgical pain in patients undergoing nephrectomy: a single-center, randomized, double-blind, controlled trial. [2022]
Ultrasound Guided Continuous Erector Spinae Plane Block versus Patient Controlled Analgesia in Open Nephrectomy for Renal Malignancies: A Randomized Controlled Study. [2022]
Pharmacokinetics of lidocaine after bilateral ESP block. [2021]
Should the Erector Spinae Plane Block Be Applied in the Pain Management of Percutaneous Nephrolithotomy? [2022]
Peak plasma concentration of total and free bupivacaine after erector spinae plane and pectointercostal fascial plane blocks. [2022]
Comparison of the efficacy of erector spinae plane block and peritubal infiltration of levobupivacaine for postoperative analgesia following percutaneous nephrolithotomy. [2022]
Erector spinae plane block vs non-steroidal anti-inflammatory drugs for severe renal colic pain: A pilot clinical feasibility study. [2021]
Comparison of the feasibility and validity of a one-level and a two-level erector spinae plane block combined with general anesthesia for patients undergoing lumbar surgery. [2023]